glp 1 agonist drug interactions Mechanisms by which GLP-1 agonists may exert beneficial effects on the A schematic overview of GLP-1
Description
This leads to decreased overall food intake [1, 2]
The clinical trial NCT07092605 is underway but results are not yet available

The primary outcome was the incremental cost-effectiveness ratio (ICER), defined as cost per QALY gained, with the willingness-to-pay threshold set at AU$28,000 per QALY [15]

Kelly and Sipos 2024)

Semaglutide is available as both an injectable and an oral tablet
Dietary adjustments are the life-blood of management - patients should eat smaller, frequent, low-fat meals and stay hydrated [10]
